New mesothelioma treatment extends survival rates - study

iStock/WILLSIE

By Ella Pickover, PA

Scientists have welcomed the “truly wonderful development” of a new drug for a hard-to-treat and aggressive form of cancer.

Researchers led by a team at Queen Mary University of London said their new treatment “quadrupled” three-year survival rates and increased average survival by 1.6 months.